Skip to main content
. 2020 Jun 10;11:534. doi: 10.3389/fneur.2020.00534

Table 5.

Effect of ticagrelor/aspirin vs. clopidogrel/aspirin on clinical outcomes within 90 days.

Outcome Ticagrelor/Aspirin N (%) (N = 197) Clopidogrel/Aspirin N (%) (N = 190) HR (95%CI) P value Adjusted HR (95%CI)# P value
Efficacy outcome
Stroke 9(4.6) 18(9.5) 0.47(0.21–1.05) 0.06 0.47(0.21–1.04) 0.06
Composite vascular events 10(5.1) 20(10.5) 0.47(0.22–1.00) 0.050 0.47(0.22–1.00) 0.049
Ischemic stroke 7(3.6) 17(9.0) 0.39(0.16–0.93) 0.03 0.38(0.16–0.92) 0.03
Safety outcome
Major bleeding 2(1.0) 2(1.1) 0.97(0.14–6.87) 0.97 1.02(0.14–7.29) 0.98
Any Bleeding 39(19.8) 25(13.2) 1.57(0.95–2.59) 0.08 1.57(0.95–2.60) 0.08

CI indicates confidence interval.

#

Adjusted for age and sex.